2,4-diamino-pyrimidines used as aurora inhibitors

摘要

The invention relates to compounds of general formula (I), in which R to R are defined as cited in claim 1. Said compounds are suitable for treating diseases that are characterised by excessive or abnormal cell proliferation. The invention also relates to the use of said compounds for producing a medicament with the aforementioned characteristics.